Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...
TOKYO -- U.S. private equity firm Bain Capital said Monday that backing down on a proposed tender offer for Japanese systems ...
U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), ...
Bain Capital LP is raising a S$460 million ($340 million) loan to back its purchase of Blackstone Inc.’s Singapore-based ...
6d
Hosted on MSNBain Capital buys Mitsubishi Tanabe Pharma for $3.3bnBain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.
U.S. private equity firm Bain Capital said it may withdraw its tender offer proposal for Japanese IT firm Fuji Soft, after ...
Bain Capital Credit, LP, a leading global credit specialist, today announced that the firm’s Private Credit Group invested $6 billion to support the g ...
Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...
Bain Capital may withdraw tender offer for Fuji Soft, after KKR raised bid in intense bidding war. Global investors target ...
Private equity firm expects $3.3bn acquisition of Tanabe will get boost from eased approval process for new medicine ...
TOKYO -- Japan's Mitsubishi Chemical Group announced on Friday the agreed sale of its pharmaceutical subsidiary, Mitsubishi ...
Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation (“Tanabe Pharma”, “MTPC” or “the Company”) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results